Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.

Kindt N, Laurent G, Nonclercq D, Journé F, Ghanem G, Duvillier H, Gabius HJ, Lechien J, Saussez S.

Int J Oncol. 2013 Jul;43(1):185-93. doi: 10.3892/ijo.2013.1944. Epub 2013 May 16.

PMID:
23677331
2.

Involvement of CD74 in head and neck squamous cell carcinomas.

Kindt N, Lechien JR, Nonclercq D, Laurent G, Saussez S.

J Cancer Res Clin Oncol. 2014 Jun;140(6):937-47. doi: 10.1007/s00432-014-1648-9. Epub 2014 Mar 25.

PMID:
24663824
3.

Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.

Kindt N, Preillon J, Kaltner H, Gabius HJ, Chevalier D, Rodriguez A, Johnson BD, Megalizzi V, Decaestecker C, Laurent G, Saussez S.

J Cancer Res Clin Oncol. 2013 May;139(5):727-37. doi: 10.1007/s00432-013-1375-7. Epub 2013 Jan 25.

PMID:
23354841
4.

CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.

Zheng YX, Yang M, Rong TT, Yuan XL, Ma YH, Wang ZH, Shen LS, Cui L.

World J Gastroenterol. 2012 May 14;18(18):2253-61. doi: 10.3748/wjg.v18.i18.2253.

5.

Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.

Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL.

J Immunol. 2006 Dec 15;177(12):8730-9.

6.

Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma.

Cheng RJ, Deng WG, Niu CB, Li YY, Fu Y.

Int J Gynecol Cancer. 2011 Aug;21(6):1004-12. doi: 10.1097/IGC.0b013e31821c45b7.

PMID:
21792010
7.

Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair.

Marsh LM, Cakarova L, Kwapiszewska G, von Wulffen W, Herold S, Seeger W, Lohmeyer J.

Am J Physiol Lung Cell Mol Physiol. 2009 Mar;296(3):L442-52. doi: 10.1152/ajplung.00525.2007. Epub 2009 Jan 9.

8.

Macrophage migration inhibitory factor inhibits the migration of cartilage end plate-derived stem cells by reacting with CD74.

Xiong CJ, Huang B, Zhou Y, Cun YP, Liu LT, Wang J, Li CQ, Pan Y, Wang H.

PLoS One. 2012;7(8):e43984. doi: 10.1371/journal.pone.0043984. Epub 2012 Aug 27. Erratum in: PLoS One. 2012;7(11). doi:10.1371/annotation/a5edef40-e46d-4810-9008-dbda429ccc2c.

9.

Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer.

Heise R, Vetter-Kauczok CS, Skazik C, Czaja K, Marquardt Y, Lue H, Merk HF, Bernhagen J, Baron JM.

Photochem Photobiol. 2012 Sep-Oct;88(5):1157-64. doi: 10.1111/j.1751-1097.2012.01108.x. Epub 2012 Mar 8.

PMID:
22324658
10.

4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.

Varinelli L, Caccia D, Volpi CC, Caccia C, De Bortoli M, Taverna E, Gualeni AV, Leoni V, Gloghini A, Manenti G, Bongarzone I.

Endocr Relat Cancer. 2015 Oct;22(5):759-75. doi: 10.1530/ERC-15-0299. Epub 2015 Jul 23.

11.

Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.

Verjans E, Noetzel E, Bektas N, Schütz AK, Lue H, Lennartz B, Hartmann A, Dahl E, Bernhagen J.

BMC Cancer. 2009 Jul 14;9:230. doi: 10.1186/1471-2407-9-230.

12.

Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.

Ohta S, Misawa A, Fukaya R, Inoue S, Kanemura Y, Okano H, Kawakami Y, Toda M.

J Cell Sci. 2012 Jul 1;125(Pt 13):3210-20. doi: 10.1242/jcs.102210. Epub 2012 Mar 27.

13.

CD74 expression and its therapeutic potential in thyroid carcinoma.

Cheng SP, Liu CL, Chen MJ, Chien MN, Leung CH, Lin CH, Hsu YC, Lee JJ.

Endocr Relat Cancer. 2015 Apr;22(2):179-90. doi: 10.1530/ERC-14-0269. Epub 2015 Jan 19.

14.

Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI.

Xiong C, Huang B, Cun Y, Aghdasi BG, Zhou Y.

Clin Orthop Relat Res. 2014 Jun;472(6):1943-54. doi: 10.1007/s11999-014-3508-y. Epub 2014 Feb 26.

15.

Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.

Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Lüscher B, Bernhagen J.

Oncogene. 2007 Aug 2;26(35):5046-59. Epub 2007 Feb 19.

PMID:
17310986
16.
17.

Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.

Richard V, Kindt N, Decaestecker C, Gabius HJ, Laurent G, Noël JC, Saussez S.

Oncol Rep. 2014 Aug;32(2):523-9. doi: 10.3892/or.2014.3272. Epub 2014 Jun 16.

18.

Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.

Fan H, Hall P, Santos LL, Gregory JL, Fingerle-Rowson G, Bucala R, Morand EF, Hickey MJ.

J Immunol. 2011 Apr 15;186(8):4915-24. doi: 10.4049/jimmunol.1003713. Epub 2011 Mar 16.

19.

Upregulation of macrophage migration inhibitory factor (MIF) and CD74, receptor for MIF, in rat bladder during persistent cyclophosphamide-induced inflammation.

Vera PL, Wang X, Meyer-Siegler KL.

Exp Biol Med (Maywood). 2008 May;233(5):620-6. doi: 10.3181/0709-RM-240. Epub 2008 Mar 28.

PMID:
18375833
20.

MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.

Klasen C, Ohl K, Sternkopf M, Shachar I, Schmitz C, Heussen N, Hobeika E, Levit-Zerdoun E, Tenbrock K, Reth M, Bernhagen J, El Bounkari O.

J Immunol. 2014 Jun 1;192(11):5273-84. doi: 10.4049/jimmunol.1302209. Epub 2014 Apr 23.

Supplemental Content

Support Center